Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Modulation of cytokine mRNA expression by brain-derived neurotrophic factor and nerve growth factor in human immune cells.

Bayas A, Kruse N, Moriabadi NF, Weber F, Hummel V, Wohleben G, Gold R, Toyka KV, Rieckmann P.

Neurosci Lett. 2003 Jan 2;335(3):155-8.

PMID:
12531456
2.

[Comment on the contribution by F. Zipp and K. P. Wandinger. Current recommendations for vaccinations in multiple sclerosis].

Rieckmann P, Moriabadi N, Flachenecker P, Toyka K.

Nervenarzt. 2001 Dec;72(12):972. German. No abstract available.

PMID:
11789446
3.

Influenza vaccination in MS: absence of T-cell response against white matter proteins.

Moriabadi NF, Niewiesk S, Kruse N, Jung S, Weissbrich B, ter Meulen V, Toyka KV, Rieckmann P.

Neurology. 2001 Apr 10;56(7):938-43.

PMID:
11294933
4.

Characterization of early immunological responses in primary cultures of differentially activated human peripheral mononuclear cells.

Kruse N, Moriabadi NF, Toyka KV, Rieckmann P.

J Immunol Methods. 2001 Jan 1;247(1-2):131-9.

PMID:
11150544
5.

Variations in cytokine mRNA expression during normal human pregnancy.

Kruse N, Greif M, Moriabadi NF, Marx L, Toyka KV, Rieckmann P.

Clin Exp Immunol. 2000 Feb;119(2):317-22.

6.

Parkinsonism following electrical injury to the hand.

Morris HR, Moriabadi NF, Lees AJ, Dick DJ, Turjanski D.

Mov Disord. 1998 May;13(3):600-2. No abstract available. Erratum in: Mov Disord 1998 Sep;13(5):864.

PMID:
9613763

Supplemental Content

Loading ...
Support Center